Trial intelligence / Profile preview

NIKOGEN: Nicotine effects on attention in schizophrenia and healthy subjects

NCT00618280Phase 2Completed

Sponsor
Heinrich Heine University Düsseldorf
Start
Jan 2008
Primary completion
Jun 2010
Modality
Transdermal Patches, Small Molecules
Countries
1
01

Overview

A Phase 2 trial of nicotine patch in Tobacco Use Disorder (TUD), schizophrenia, sponsored by Heinrich Heine University Düsseldorf. Started Jan 2008; status: completed.

02

Drugs

nicotine patch
03

Conditions

Tobacco Use Disorder (TUD)schizophrenia

Beyond the preview

Go deeper on NCT00618280.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00618280.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call